Home/Filings/4/A/0001273636-19-000017
4/A//SEC Filing

Feinsod Matthew 4/A

Accession 0001273636-19-000017

CIK 0001273636other

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 4:39 PM ET

Size

4.8 KB

Accession

0001273636-19-000017

Insider Transaction Report

Form 4/AAmended
Period: 2019-06-11
Feinsod Matthew
Interim Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2019-06-11$3.70/sh685$2,53554,644 total
Footnotes (1)
  • [F1]This Form 4/A is being filed to correct an administrative error in the reported price of the securities forfeited for tax witholding purposes.

Issuer

APPLIED GENETIC TECHNOLOGIES CORP

CIK 0001273636

Entity typeother

Related Parties

1
  • filerCIK 0001716950

Filing Metadata

Form type
4/A
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:39 PM ET
Size
4.8 KB